IgM nephropathy: Clinical picture and long-term prognosis

American Journal of Kidney Diseases

Volumn 41, Issue 2, 2003, Pages 343-350

  Myllymäki, Juhani ^a,b   Saha, Heikki ^a,b   Mustonen, Jukka ^a,b   Helin, Heikki ^a,b   Pasternack, Amos ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Focal and segmental glomerulosclerosis (FSGS); Hematuria (HU); Immunoglobulin M (IgM) nephropathy; Mesangial glomerulonephritis; Nephrotic syndrome (NS); Proteinuria (PU)

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN M; PREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; HYPERTENSION; IMMUNOGLOBULIN DEPOSITION; IMMUNOGLOBULIN M NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PROGNOSIS; PROTEINURIA;

EID: 0037308055     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50042     Document Type: Article

References (30)

1. Cohen AH, Border WA, Glassock RJ: Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 38:610-619, 1978
2. Bhasin HK, Abuelo JG, Nayak R, Esparza AR: Mesangial proliferative glomerulonephritis. Lab Invest 39:21-29, 1978
3. Helin H, Mustonen J, Pasternack A, Antonen J: IgM-associated glomerulonephritis. Nephron 31:11-16, 1982
4. Border WA: Distinguishing minimal-change disease from mesangial disorders. Kidney Int 34:419-434, 1988
5. Lin CY, Chen CH, Lee PP: In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy. Pediatr Nephrol 3:254-258, 1989
6. O'Donoghue DJ, Lawler W, Hunt LP, Acheson EJ, Mallick NP: IgM-associated primary diffuse mesangial proliferative glomerulonephritis: Natural history and prognostic indicators. Q J Med 79:333-350, 1991
7. Korbet SM: Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 9:1333-1340, 1998
8. Vilches AR, Turner DR, Cameron JS, Ogg CS, Chantler C, Williams DG: Significance of mesangial IgM deposition in "minimal change" nephrotic syndrome. Lab Invest 46:10-15, 1982
9. Ji-Yun Y, Melvin T, Sibley R, Michael AF: No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int 25:100-106, 1984
10. Lawler W, Williams G, Tarpey P, Mallick NP: IgM associated primary diffuse mesangial proliferative glomerulonephritis. J Clin Pathol 33:1029-1038, 1980
11. Kopolovic J, Shvil Y, Pomeranz A, Ron N, Rubinger D, Oren R: IgM nephropathy: Morphological study related to clinical findings. Am J Nephrol 7:275-280, 1987
12. Cohen AH, Border WA: Mesangial proliferative glomerulonephritis. Semin Nephrol 2:228-240, 1982
13. Tejani A, Nicastri AD: Mesangial IgM nephropathy. Nephron 35:1-5, 1983
14. Saha H, Mustonen J, Pasternack A, Helin H: Clinical follow-up of 54 patients with IgM-nephropathy. Am J Nephrol 9:124-128, 1989
15. Hirszel P, Yamase HT, Carney WR, et al: Mesangial proliferative glomerulonephritis with IgM deposits. Clinicopathologic analysis and evidence for morphologic transitions. Nephron 38:100-108, 1984
16. Aubert J, Humair L, Chatelanat F, De Torrente A: IgM-associated mesangial proliferative glomerulonephritis and focal and segmental hyalinosis with nephrotic syndrome. Am J Nephrol 5:445-449, 1985
17. Anonymous: Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 98:649-658, 1996
18. Anonymous: Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians. Arch Dis Child 70:151-157, 1994
19. Chen WP, Lin CY: Augmented expression of interleukin-6 and interleukin-1 genes in the mesangium of IgM mesangial nephropathy. Nephron 68:10-19, 1994
20. Cavallo T, Johnson MP: Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron 27:281-284, 1981
21. Disciullo SO, Abuelo JG, Moalli K, Pezzullo JC: Circulating heavy IgM in IgM nephropathy. Clin Exp Immunol 73:395-400, 1988
22. Vangelista A, Frasca G, Biagini G, Bonomini V: Long term study of mesangial proliferative glomerulonephritis with IgM deposits. Proc Eur Dial Transplant Assoc 18:503-507, 1981
23. Al-Eisa A, Carter JE, Lirenman DS, Magil AB: Childhood IgM nephropathy: Comparison with minimal change disease. Nephron 72:37-43, 1996
24. Gonzalo A, Mampaso F, Gallego N, Quereda C, Fierro C, Ortuno J: Clinical significance of IgM mesangial deposits in the nephrotic syndrome. Nephron 41:246-249, 1985
25. Korbet SM, Genchi RM, Borok RZ, Schwartz MM: The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 27:647-651, 1996
26. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 11:319-329, 2000
27. Besbas N, Topaloglu R, Saatci O, Bakkaloglu A: Long-term follow-up in children with steroid-resistant nephrotic syndrome. Clin Pediatr 31:283-288, 1992
28. Shoji T, Nakanishi I, Suzuki A, et al: Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am J Kidney Dis 35:194-201, 2000
29. Pozzi C, Bolasco PG, Fogazzi GB, et al: Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet 353:883-887, 1999
30. Mustonen J, Pasternack A, Helin H, Nikkilä M: Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis. Am J Nephrol 5:150-157, 1984